Metlife (MET) Receivables - Other (2009 - 2025)

Metlife has reported Receivables - Other for 17 years, with the latest figure at $46.0 million in Q4 2025.

• On a quarterly basis, Receivables - Other fell 25.81% year-over-year to $46.0 million in Q4 2025; TTM through Dec 2025 was $46.0 million, a 25.81% decrease from a year earlier, with the FY2025 full-year figure at $375.0 million, up 66.67% from the prior year.
• Receivables - Other was $46.0 million for Q4 2025 at Metlife, down from $300.0 million in the prior quarter.
• The five-year high for Receivables - Other was $300.0 million in Q1 2024, with the low at $35.0 million in Q4 2021.
• Average Receivables - Other over 5 years is $164.8 million, with a median of $172.5 million recorded in 2021.
• The sharpest annual moves came in 2023 and 2024: Receivables - Other jumped 316.67% in 2023, then slumped 75.2% in 2024.
• Over 5 years, Receivables - Other stood at $35.0 million in 2021, then surged by 71.43% to $60.0 million in 2022, then surged by 316.67% to $250.0 million in 2023, then plunged by 75.2% to $62.0 million in 2024, then slipped by 25.81% to $46.0 million in 2025.
• The last three Receivables - Other figures came in at $46.0 million (Q4 2025), $300.0 million (Q1 2025), and $62.0 million (Q4 2024), per Business Quant data.